GI symptoms are actually a sign that the medication is working
and the proportion of patients achieving body weight loss of 5-10% [3]
We think Amgen's going to be an important participant in this global health crisis. Amgen joins an increasingly competitive field: Eli Lilly recently saw its chronic weight product, injectable ZepBound (tirzepatide), approved by the FDA, while Novo Nordisk already has two weight-loss peptides on the market, Saxenda (liraglutide) and Wegovy (semaglutide)
13 C NMR (100 MHz, DMSO-d6) = 106.9, 100.6, 86.8, 86.0, 30.5, 22.0, 21.9, 18.4, 18.3
Your GLP-1 pens and vials can be any size
So let's slow down, look at the actual clinical science, and figure out what these drugs really doand more importantly, what they do to your body